North America Extracorporeal CO2 Removal Devices Market Size and Forecast (2021 - 2031)
The North America Extracorporeal CO2 Removal Devices Market is projected to grow significantly, reaching an estimated US$ 75.4 million by 2031, up from US$ 45.8 million in 2024, reflecting a compound annual growth rate (CAGR) of 7.5% from 2025 to 2031. This growth is driven by several factors, including the region's advanced healthcare infrastructure, the increasing prevalence of respiratory diseases, and the adoption of innovative medical technologies.
The North American market for Extracorporeal CO2 Removal (ECCO?R) devices is expanding rapidly, particularly in the United States and Canada, which are known for their efficient healthcare systems and substantial investments in intensive care and respiratory therapy. The rise in chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) has led to a heightened demand for respiratory support solutions, thereby increasing the utilization of ECCO?R devices. Furthermore, the robust clinical research environment in North America, coupled with the presence of leading medical device manufacturers, has facilitated the development and commercialization of new ECCO?R technologies.
The market is also supported by favorable insurance policies and a growing interest among healthcare providers in less invasive methods that can serve as alternatives or supplements to mechanical ventilation. The COVID-19 pandemic has further accelerated the need for advanced respiratory care options, positively impacting market growth.
Collaborations between hospitals, research centers, and medical device companies have fostered the development of new products, enhancing their usability in clinical settings. While the high costs associated with these complex treatments pose a challenge, ongoing efforts to demonstrate clinical efficacy and cost-effectiveness through trials and real-world evidence are helping to sustain market momentum. Regulatory support, particularly from the US FDA, which favors medical device innovation and expedited approval processes, has also facilitated market access for new ECCO?R solutions.
Investments in healthcare infrastructure and the integration of digital health technologies are expected to improve the management of patients with respiratory failure, contributing to a positive outlook for the ECCO?R market in North America. The combination of skilled clinicians, technological advancements, supportive policies, and a high prevalence of respiratory diseases positions North America as a leader in the ECCO?R devices market, with promising prospects for improving healthcare outcomes in respiratory care.
Market Segmentation Analysis
The North America Extracorporeal CO2 Removal Devices Market is segmented by product, application, and end user:
A significant trend in the ECCO?R devices market is the integration of Artificial Intelligence (AI) and Machine Learning (ML), transforming these life-support devices into intelligent, self-optimizing therapeutic platforms. This integration is expected to revolutionize critical care by providing personalized therapy, automated adjustments, and real-time complication predictions. The current generation of ECCO?R devices requires substantial manual intervention, with healthcare personnel needing to make complex decisions regarding blood flow and anticoagulation. AI and ML can automate these processes, creating closed-loop control systems that adjust therapy based on real-time patient data.
Major manufacturers, including Medtronic and Getinge, are focusing on enhancing their ECCO?R systems with advanced data analytics capabilities. Future designs may incorporate micro-sensors that continuously feed data into ML algorithms, enabling predictive analytics for thrombosis and hemolysis, optimizing decarboxylation, and improving decision support systems for patient management.
Country Insights
The North American ECCO?R market is primarily driven by the United States, which holds the largest market share. The US benefits from a stable healthcare infrastructure, a high prevalence of respiratory disorders, and a strong clinical research environment. The widespread use of ECCO?R systems in tertiary care hospitals and university medical centers, along with financial incentives for treatment coverage, has bolstered market growth. Companies like Medtronic, Getinge, and ALung Technologies are at the forefront of advancing ECCO?R systems, focusing on optimizing technology and improving patient outcomes.
Company Profiles
Key players in the North America ECCO?R devices market include Terumo Corp, Medtronic Plc, Baxter International Inc, LivaNova Plc, Getinge AB, and others. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.
Research Methodology
The report's findings are based on a combination of secondary and primary research. Secondary research involved gathering data from various sources, including company reports, industry publications, and government documents. Primary research included interviews with industry stakeholders to validate findings and gain insights into market dynamics.
The North American market for Extracorporeal CO2 Removal (ECCO?R) devices is expanding rapidly, particularly in the United States and Canada, which are known for their efficient healthcare systems and substantial investments in intensive care and respiratory therapy. The rise in chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) has led to a heightened demand for respiratory support solutions, thereby increasing the utilization of ECCO?R devices. Furthermore, the robust clinical research environment in North America, coupled with the presence of leading medical device manufacturers, has facilitated the development and commercialization of new ECCO?R technologies.
The market is also supported by favorable insurance policies and a growing interest among healthcare providers in less invasive methods that can serve as alternatives or supplements to mechanical ventilation. The COVID-19 pandemic has further accelerated the need for advanced respiratory care options, positively impacting market growth.
Collaborations between hospitals, research centers, and medical device companies have fostered the development of new products, enhancing their usability in clinical settings. While the high costs associated with these complex treatments pose a challenge, ongoing efforts to demonstrate clinical efficacy and cost-effectiveness through trials and real-world evidence are helping to sustain market momentum. Regulatory support, particularly from the US FDA, which favors medical device innovation and expedited approval processes, has also facilitated market access for new ECCO?R solutions.
Investments in healthcare infrastructure and the integration of digital health technologies are expected to improve the management of patients with respiratory failure, contributing to a positive outlook for the ECCO?R market in North America. The combination of skilled clinicians, technological advancements, supportive policies, and a high prevalence of respiratory diseases positions North America as a leader in the ECCO?R devices market, with promising prospects for improving healthcare outcomes in respiratory care.
Market Segmentation Analysis
The North America Extracorporeal CO2 Removal Devices Market is segmented by product, application, and end user:
- By Product: The market is divided into Extracorporeal CO2 Devices and Consumables, with the Extracorporeal CO2 Devices segment leading in 2024.
- By Application: The market is categorized into Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and others, with COPD being the dominant application in 2024.
- By End User: The market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and others, where Hospitals and Clinics held the largest share in 2024.
A significant trend in the ECCO?R devices market is the integration of Artificial Intelligence (AI) and Machine Learning (ML), transforming these life-support devices into intelligent, self-optimizing therapeutic platforms. This integration is expected to revolutionize critical care by providing personalized therapy, automated adjustments, and real-time complication predictions. The current generation of ECCO?R devices requires substantial manual intervention, with healthcare personnel needing to make complex decisions regarding blood flow and anticoagulation. AI and ML can automate these processes, creating closed-loop control systems that adjust therapy based on real-time patient data.
Major manufacturers, including Medtronic and Getinge, are focusing on enhancing their ECCO?R systems with advanced data analytics capabilities. Future designs may incorporate micro-sensors that continuously feed data into ML algorithms, enabling predictive analytics for thrombosis and hemolysis, optimizing decarboxylation, and improving decision support systems for patient management.
Country Insights
The North American ECCO?R market is primarily driven by the United States, which holds the largest market share. The US benefits from a stable healthcare infrastructure, a high prevalence of respiratory disorders, and a strong clinical research environment. The widespread use of ECCO?R systems in tertiary care hospitals and university medical centers, along with financial incentives for treatment coverage, has bolstered market growth. Companies like Medtronic, Getinge, and ALung Technologies are at the forefront of advancing ECCO?R systems, focusing on optimizing technology and improving patient outcomes.
Company Profiles
Key players in the North America ECCO?R devices market include Terumo Corp, Medtronic Plc, Baxter International Inc, LivaNova Plc, Getinge AB, and others. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.
Research Methodology
The report's findings are based on a combination of secondary and primary research. Secondary research involved gathering data from various sources, including company reports, industry publications, and government documents. Primary research included interviews with industry stakeholders to validate findings and gain insights into market dynamics.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 North America Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 North America
10.1.1 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 United States: North America Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 United States: North America Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 United States: North America Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Canada: North America Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 Canada: North America Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 Canada: North America Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 Mexico: North America Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 Mexico: North America Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 Mexico: North America Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - NORTH AMERICA MARKET ANALYSIS
6.1 North America Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 North America Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 North America
10.1.1 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 North America Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 United States: North America Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 United States: North America Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 United States: North America Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Canada: North America Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 Canada: North America Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 Canada: North America Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 Mexico: North America Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 Mexico: North America Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 Mexico: North America Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. North America Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Heat Map Analysis by Key Players
Table 1. North America Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. North America Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. North America Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. North America Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. North America Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. North America Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Company Positioning & Concentration
Figure 1. North America Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. North America Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. North America Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. North America Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. North America Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. United States: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Canada: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Mexico: North America Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Company Positioning & Concentration
